The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives
Open accessAbstract
Next-generation probiotics (NGPs) represent an innovative group of beneficial bacteria that are currently undergoing research and development. NGPs are designed not only for conventional use as foods or dietary supplements but are also tailored for pharmaceutical applications. Research indicates that NGPs show therapeutic promise in addressing various chronic ailments. Offering multiple advantages over conventional probiotics, NGPs present opportunities for personalized probiotic therapies, involvement in synthetic biology and gene editing, participation in combination therapies, targeted delivery methods, and application in therapeutic settings. Our review discusses the potential therapeutic effect of the NGPs, covering diverse research trajectories for NGPs, including their identification, characterization, and targeted delivery. Furthermore, this review elucidates the influence of NGPs on critical aspects of human health, specifically, gut health, immune function, and broader health outcomes. Mechanistic insights encompass the production of bioactive compounds, competitive interactions with pathogenic bacteria, the modulation of immune cell activity, and the reinforcement of the gut barrier. What is noteworthy is that the current review points out the prevalent NGP strains and their diverse sources, providing a highlight for the comprehensive framework for understanding their potential applications and their future benefits in the domain of advanced therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of action of probiotics
Plaza-Diaz, J., Ruiz-Ojeda, F. J., Gil-Campos, M., & Gil, A. (2019) · Advances in Nutrition · doi:10.1093/advances/nmy063 · Cited by 1,423
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
Cani, P. D., Depommier, C., Derrien, M., Everard, A., & de Vos, W. M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00631-9 · Cited by 1,192
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
O’Toole, P. W., Marchesi, J. R., & Hill, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.57 · Cited by 971 · cited 3×
“The development of NGPs also involves operational differences, as they are often investigated by laboratories previously engaged in probiotic and microbiome research and have a development trajectory based on the probiotic experience in the laboratory [7].”
BackgroundInfluentialProbiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health
Mazziotta, C., Tognon, M., Martini, F., Torreggiani, E., & Rotondo, J. C. (2023) · Cells · doi:10.3390/cells12010184 · Cited by 889 · cited 4×
“The stimulation of the immune system to reduce inflammation in the gut is another mechanism, particularly in IBD and other conditions that involve gut inflammation [88].”
BackgroundInfluentialA Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease
Braat, H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J., van Deventer, S. J. H., Neirynck, S., Peppelenbosch, M. P., & Steidler, L. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.03.028 · Cited by 786 · cited 1×
“Noteworthy examples include a 2006 phase I clinical trial conducted by Braat et al., which assessed the safety and efficacy of a genetically modified L. lactis strain [187,188].”
BackgroundSynchronized cycles of bacterial lysis for in vivo delivery
Din, M. O., Danino, T., Prindle, A., Skalak, M., Selimkhanov, J., Allen, K., Julio, E., Atolia, E., Tsimring, L. S., Bhatia, S. N., et al. (2016) · Nature · doi:10.1038/nature18930 · Cited by 784
Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767 · cited 1×
“A mixed-species probiotic that included L. casei was also found to reduce depression and depressive-like symptoms in MDD patients and healthy individuals [134].”
BackgroundEngineered probiotics for local tumor delivery of checkpoint blockade nanobodies
Gurbatri, C. R., Lia, I., Vincent, R., Coker, C., Castro, S., Treuting, P. M., Hinchliffe, T. E., Arpaia, N., & Danino, T. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0876 · Cited by 647 · cited 1×
“Consequently, this process inhibits tumor growth and prevents metastasis [177].”
BackgroundMetabolic modulation of tumours with engineered bacteria for immunotherapy
Canale, F. P., Basso, C., Antonini, G., Perotti, M., Li, N., Sokolovska, A., Neumann, J., James, M. J., Geiger, S., Jin, W., et al. (2021) · Nature · doi:10.1038/s41586-021-04003-2 · Cited by 619 · cited 1×
“Similar research has been conducted using engineered EcN to target the angiogenic inhibitor TUM-5 and tumor suppressor p53, as well as converting tumor metabolic waste into L-arginine, which boosts the anti-tumor immune response [178].”
MethodProbiotics, prebiotics and amelioration of diseases
Tsai, Y.-L., Lin, T.-L., Chang, C.-J., Wu, T.-R., Lai, W.-F., Lu, C.-C., & Lai, H.-C. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-018-0493-6 · Cited by 388
Research works printed but not linked: 178
- Fakruddin, 2022, Next-Generation Probiotics-The Future of Biotherapeutics, Microb. Bioact., 5, 156
- Salas-Jara, M.J., Ilabaca, A., Vega, M., and García, A. (2016). Biofilm forming Lactobacillus: New challenges for the development of probiotics. Microorganisms, 4. · DOI · Paper page
- Chugh, 2020, Bioactive compounds produced by probiotics in food products, Curr. Opin. Food Sci., 32, 76, 10.1016/j.cofs.2020.02.003 · DOI · Paper page
- Capasso, 2021, Involvement of probiotics and postbiotics in the immune system modulation, Biologics, 1, 89, 10.3390/biologics1020006 · DOI · Paper page
- Shanahan, 2004, Probiotics in inflammatory bowel disease—Therapeutic rationale and role, Adv. Drug Deliv. Rev., 56, 809, 10.1016/j.addr.2003.11.003 · DOI
- Singh, 2021, Next-generation probiotics: A promising approach towards designing personalized medicine, Crit. Rev. Microbiol., 47, 479, 10.1080/1040841X.2021.1902940 · DOI
- Steidler, 2003, Genetically engineered probiotics, Best. Pract. Res. Clin. Gastroenterol., 17, 861, 10.1016/S1521-6918(03)00072-6 · DOI
- Zhang, H., Duan, Y., Cai, F., Cao, D., Wang, L., Qiao, Z., Hong, Q., Li, N., Zheng, Y., and Su, M. (2022). Next-Generation Probiotics: Microflora Intervention to Human Diseases. BioMed Res. Int., 2022. · DOI
- Lin, 2019, Investiture of next generation probiotics on amelioration of diseases–Strains do matter, Med. Microecol., 1, 100002, 10.1016/j.medmic.2019.100002 · DOI
- Danilenko, 2021, Common inflammatory mechanisms in COVID-19 and Parkinson’s diseases: The role of microbiome, pharmabiotics and postbiotics in their prevention, J. Inflamm. Res., 14, 6349, 10.2147/JIR.S333887 · DOI
- Aljutaily, 2020, Probiotic-enriched milk and dairy products increase gut microbiota diversity: A comparative study, Nutr. Res., 82, 25, 10.1016/j.nutres.2020.06.017 · DOI
- Taha-Abdelaziz, K., Singh, M., Sharif, S., Sharma, S., Kulkarni, R.R., Alizadeh, M., Yitbarek, A., and Helmy, Y.A. (2023). Intervention Strategies to Control Campylobacter at Different Stages of the Food Chain. Microorganisms, 11. · DOI
- Winker, 1991, A definition of the domains Archaea, Bacteria and Eucarya in terms of small subunit ribosomal RNA characteristics, Syst. Appl. Microbiol., 14, 305, 10.1016/S0723-2020(11)80303-6 · DOI · Paper page
- Philippe, 1996, 16S rRNA and 16S to 23S internal transcribed spacer sequence analyses reveal inter-and intraspecific Bifidobacterium phylogeny, Int. J. Syst. Evol. Microbiol., 46, 102
- Meshref, 2014, Screening of antagonistic activity of probiotic bacteria against some food-borne pathogens, J. Food Biosci. Technol., 4, 1
- Kathayat, 2022, In Vitro and In Vivo Evaluation of Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis Bb12 Against Avian Pathogenic Escherichia coli and Identification of Novel Probiotic-Derived Bioactive Peptides, Probiotics Antimicrob. Proteins, 14, 1012, 10.1007/s12602-021-09840-1 · DOI
- Dargahi, 2021, Immune modulatory effects of probiotic Streptococcus thermophilus on human monocytes, Biologics, 1, 396, 10.3390/biologics1030023 · DOI
- Helmy, 2022, Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens, Infect. Immun., 90, e0033722, 10.1128/iai.00337-22 · DOI
- Helmy, 2021, Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection, Gut Microbes, 13, 1857514, 10.1080/19490976.2020.1857514 · DOI
- Helmy, Y.A., Taha-Abdelaziz, K., Hawwas, H.A.E.-H., Ghosh, S., AlKafaas, S.S., Moawad, M.M., Saied, E.M., Kassem, I.I., and Mawad, A.M. (2023). Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens. Antibiotics, 12. · DOI · Paper page
- Lamichhane, B., Mawad, A.M., Saleh, M., Kelley, W.G., Harrington, P.J., Lovestad, C.W., Amezcua, J., Sarhan, M.M., El Zowalaty, M.E., and Ramadan, H. (2024). Salmonellosis: An Overview of Epidemiology, Pathogenesis, and Innovative Approaches to Mitigate the Antimicrobial Resistant Infections. Antibiotics, 13. · DOI · Paper page
- Grimoud, 2010, In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics, Anaerobe, 16, 493, 10.1016/j.anaerobe.2010.07.005 · DOI
- Daneshazari, 2023, Bacillus subtilis isolates from camel milk as probiotic candidates, Sci. Rep., 13, 3387, 10.1038/s41598-023-30507-0 · DOI
- Santivarangkna, C. (2015). Advances in Probiotic Technology, CRC Press.
- Pearce, 2018, Intestinal in vitro and ex vivo models to study host-microbiome interactions and acute stressors, Front. Physiol., 9, 1584, 10.3389/fphys.2018.01584 · DOI · Paper page
- Frece, 2005, In vivo testing of functional properties of three selected probiotic strains, World J. Microbiol. Biotechnol., 21, 1401, 10.1007/s11274-005-5741-8 · DOI
- Xie, 2013, Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes, Electrophoresis, 34, 2787, 10.1002/elps.201300017 · DOI
- Dave, 2012, The human gut microbiome: Current knowledge, challenges, and future directions, Transl. Res., 160, 246, 10.1016/j.trsl.2012.05.003 · DOI · Paper page
- Chang, 2019, Next generation probiotics in disease amelioration, J. Food Drug Anal., 27, 615, 10.1016/j.jfda.2018.12.011 · DOI · Paper page
- Khan, 2023, Synergy and oxygen adaptation for development of next-generation probiotics, Nature, 620, 381, 10.1038/s41586-023-06378-w · DOI · Paper page
- Stanton, C., Desmond, C., Coakley, M., Collins, J.K., Fitzgerald, G., and Ross, R.P. (2003). Handbook of Fermented Functional Foods, CRC Press.
- Fuller, R. (2012). Probiotics: The Scientific Basis, Springer.
- Yao, 2020, Progress in microencapsulation of probiotics: A review, Compr. Rev. Food Sci. Food Saf., 19, 857, 10.1111/1541-4337.12532 · DOI · Paper page
- Quijano, 2011, Probiotics and prebiotics—Perspectives and challenges, J. Sci. Food Agric., 91, 1341, 10.1002/jsfa.4367 · DOI · Paper page
- Daniel, 2013, Probiotics from research to market: The possibilities, risks and challenges, Curr. Opin. Microbiol., 16, 284, 10.1016/j.mib.2013.06.008 · DOI · Paper page
- Rokka, 2010, Protecting probiotic bacteria by microencapsulation: Challenges for industrial applications, Eur. Food Res. Technol., 231, 1, 10.1007/s00217-010-1246-2 · DOI · Paper page
- Ranjan, A., Arora, J., Chauhan, A., Basniwal, R.K., Kumari, A., Rajput, V.D., Prazdnova, E.V., Ghosh, A., Mukerjee, N., and Mandzhieva, S.S. (2022). Advances in characterization of probiotics and challenges in industrial application. Biotechnol. Genet. Eng. Rev., 1–44. · DOI
- Li, S., and Zhang, Y.-X. (2023). Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics. Crit. Rev. Microbiol., 1–14. · DOI
- Renuka, B., and Borse, B. (2023). Novel Processing Methods for Plant-Based Health Foods, Apple Academic Press.
- Yunes, 2022, Lactobacilli: Legal Regulation and Prospects for New Generation Drugs, Appl. Biochem. Microbiol., 58, 652, 10.1134/S0003683822050179 · DOI
- Khan, S.T., and Malik, A. (2019). Health and Safety Aspects of Food Processing Technologies, Springer.
- Wolfe, W., Xiang, Z., Yu, X., Li, P., Chen, H., Yao, M., Fei, Y., Huang, Y., Yin, Y., and Xiao, H. (2023). The Challenge of Applications of Probiotics in Gastrointestinal Diseases. Adv. Gut Microbiome Res., 2023. · DOI
- Gullifa, G., Risoluti, R., Mazzoni, C., Barone, L., Papa, E., Battistini, A., Martin Fraguas, R., and Materazzi, S. (2023). Microencapsulation by a Spray Drying Approach to Produce Innovative Probiotics-Based Products Extending the Shelf-Life in Non-Refrigerated Conditions. Molecules, 28. · doi:10.3390/molecules28020860
- More, 2023, Duocapsule and alternative shell material to gelatin: Advancement in capsule formulation, World J. Biol. Pharm. Health Sci., 13, 221, 10.30574/wjbphs.2023.13.2.0076 · doi:10.30574/wjbphs.2023.13.2.0076
- Yoha, 2021, Targeted delivery of probiotics: Perspectives on research and commercialization, Probiotics Antimicrob. Proteins, 14, 15, 10.1007/s12602-021-09791-7 · DOI · Paper page
- Sarao, 2017, Probiotics, prebiotics, and microencapsulation: A review, Crit. Rev. Food Sci. Nutr., 57, 344, 10.1080/10408398.2014.887055 · DOI · Paper page
- Nezamdoost-Sani, N., Khaledabad, M.A., Amiri, S., and Khaneghah, A.M. (2023). Alginate and derivatives hydrogels in encapsulation of probiotic bacteria: An updated review. Food Biosci., 52. · DOI · Paper page
- Vidhyalakshmi, 2009, Encapsulation “the future of probiotics”—A review, Adv. Biol. Res., 3, 96
- Mawad, 2018, E. coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro, Appl. Microbiol. Biotechnol., 102, 10675, 10.1007/s00253-018-9417-3 · DOI
- Coghetto, 2016, Probiotics production and alternative encapsulation methodologies to improve their viabilities under adverse environmental conditions, Int. J. Food Sci. Nutr., 67, 929, 10.1080/09637486.2016.1211995 · DOI
- Torp, 2022, Optimizing oral delivery of next generation probiotics, Trends Food Sci. Technol., 119, 101, 10.1016/j.tifs.2021.11.034 · DOI
- Liu, 2023, Novel Colloidal Food Ingredients: Protein Complexes and Conjugates, Annu. Rev. Food Sci. Technol., 14, 35, 10.1146/annurev-food-060721-023522 · DOI
- Nath, P.C., Debnath, S., Sharma, M., Sridhar, K., Nayak, P.K., and Inbaraj, B.S. (2023). Recent Advances in Cellulose-Based Hydrogels: Food Applications. Foods, 12. · DOI
- Mugwanda, K., Hamese, S., Van Zyl, W.F., Prinsloo, E., Du Plessis, M., Dicks, L.M., and Thimiri Govinda Raj, D.B. (2023). Recent advances in genetic tools for engineering probiotic lactic acid bacteria. Biosci. Rep., 43. · DOI
- Mandal, 2014, Recombinant probiotics with antimicrobial peptides: A dual strategy to improve immune response in immunocompromised patients, Drug Discov. Today, 19, 1045, 10.1016/j.drudis.2014.05.019 · DOI
- Torres-Sánchez, A., Ruiz-Rodríguez, A., Ortiz, P., Moreno, M.A., Ampatzoglou, A., Gruszecka-Kosowska, A., Monteoliva-Sánchez, M., and Aguilera, M. (2022). Exploring Next Generation Probiotics for Metabolic and Microbiota Dysbiosis Linked to Xenobiotic Exposure: Holistic Approach. Int. J. Mol. Sci., 23. · DOI
- Helmy, Y.A., Kassem, I.I., Kumar, A., and Rajashekara, G. (2017). In Vitro Evaluation of the Impact of the Probiotic E. coli Nissle 1917 on Campylobacter jejuni’s Invasion and Intracellular Survival in Human Colonic Cells. Front. Microbiol., 8. · DOI
- Martín, R., Miquel, S., Benevides, L., Bridonneau, C., Robert, V., Hudault, S., Chain, F., Berteau, O., Azevedo, V., and Chatel, J.M. (2017). Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: A step forward in the use of F. prausnitzii as a next-generation probiotic. Front. Microbiol., 8. · DOI · Paper page
- Krzyżek, P., Marinacci, B., Vitale, I., and Grande, R. (2023). Extracellular Vesicles of Probiotics: Shedding Light on the Biological Activity and Future Applications. Pharmaceutics, 15. · DOI
- Rodovalho, V.d.R., Luz, B.S.R.d., Rabah, H., Do Carmo, F.L.R., Folador, E.L., Nicolas, A., Jardin, J., Briard-Bion, V., Blottière, H., and Lapaque, N. (2020). Extracellular vesicles produced by the probiotic Propionibacterium freudenreichii CIRM-BIA 129 mitigate inflammation by modulating the NF-κB pathway. Front. Microbiol., 11. · DOI
- Yu, 2016, The potential role of probiotics in cancer prevention and treatment, Nutr. Cancer, 68, 535, 10.1080/01635581.2016.1158300 · DOI
- Chang, 2012, Effect of Lactobacillus acidophilus KFRI342 on the development of chemically induced precancerous growths in the rat colon, J. Med. Microbiol., 61, 361, 10.1099/jmm.0.035154-0 · DOI
- Torres-Maravilla, E., Boucard, A.-S., Mohseni, A.H., Taghinezhad, S.S., Cortes-Perez, N.G., and Bermúdez-Humarán, L.G. (2021). Role of gut microbiota and probiotics in colorectal cancer: Onset and progression. Microorganisms, 9. · DOI
- Boesmans, 2018, Butyrate producers as potential next-generation probiotics: Safety assessment of the administration of Butyricicoccus pullicaecorum to healthy volunteers, Msystems, 3, e00094-18, 10.1128/mSystems.00094-18 · DOI
- Thiraworawong, 2014, Anti-inflammatory Properties of Gastric-derived Lactobacillus plantarum XB 7 in the Context of Helicobacter pylori Infection, Helicobacter, 19, 144, 10.1111/hel.12105 · DOI
- Asoudeh-Fard, A., Barzegari, A., Dehnad, A., Bastani, S., Golchin, A., and Omidi, Y. (2017). Lactobacillus plantarum induces apoptosis in oral cancer KB cells through upregulation of PTEN and downregulation of MAPK signalling pathways. BioImpacts BI, 7. · DOI
- Maleki-Kakelar, H., Dehghani, J., Barzegari, A., Barar, J., Shirmohamadi, M., Sadeghi, J., and Omidi, Y. (2020). Lactobacillus plantarum induces apoptosis in gastric cancer cells via modulation of signaling pathways in Helicobacter pylori. BioImpacts BI, 10. · DOI
- Mendoza, 2019, Potential effect of probiotics in the treatment of breast cancer, Oncol. Rev., 13, 134, 10.4081/oncol.2019.422 · DOI
- Tata, K., Ramadevi, S., Shelin, R., and Meenakshi, S. (2023). Handbook of Animal Models and Its Uses in Cancer Research, Springer.
- Toi, 2013, Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study, Curr. Nutr. Food Sci., 9, 194, 10.2174/15734013113099990001 · DOI
- Wan, 2023, Inhibitory effect and mechanism of Lactobacillus crispatus on cervical precancerous cells Ect1/E6E7 and screening of early warning factors, Infect. Agents Cancer, 18, 5, 10.1186/s13027-023-00483-1 · DOI
- Aganja, R.P., Sivasankar, C., Senevirathne, A., and Lee, J.H. (2022). Salmonella as a Promising Curative Tool against Cancer. Pharmaceutics, 14. · DOI
- Chang, 2020, A gut butyrate-producing bacterium Butyricicoccus pullicaecorum regulates short-chain fatty acid transporter and receptor to reduce the progression of 1, 2-dimethylhydrazine-associated colorectal cancer, Oncol. Lett., 20, 327, 10.3892/ol.2020.12190 · DOI
- Lee, 2017, Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population, Neurogastroenterol. Motil., 29, e13003, 10.1111/nmo.13003 · DOI
- Bernstein, 2010, World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010, Inflamm. Bowel Dis., 16, 112, 10.1002/ibd.21048 · DOI · Paper page
- Hizay, 2023, Lactobacillus acidophilus regulates abnormal serotonin availability in experimental ulcerative colitis, Anaerobe, 80, 102710, 10.1016/j.anaerobe.2023.102710 · DOI
- Kligler, 2008, Probiotics, Am. Fam. Physician, 78, 1073
- Agostini, 2012, A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats, Neurogastroenterol. Motil., 24, 376-e172, 10.1111/j.1365-2982.2011.01865.x · DOI
- Bonfrate, 2020, Effects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients, Eur. J. Clin. Investig., 50, e13201, 10.1111/eci.13201 · DOI
- Sawant, 2012, Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome, World J. Gastroenterol. WJG, 18, 4012, 10.3748/wjg.v18.i30.4012 · DOI · Paper page
- Leylabadlo, 2022, The role of gut microbiota in the treatment of irritable bowel syndrome, Rev. Med. Microbiol., 33, e89, 10.1097/MRM.0000000000000284 · DOI
- Mazzawi, T. (2022). Gut Microbiota Manipulation in Irritable Bowel Syndrome. Microorganisms, 10. · DOI
- Mao, 2024, Blautia producta displays potential probiotic properties against dextran sulfate sodium-induced colitis in mice, Food Sci. Hum. Wellness, 13, 709, 10.26599/FSHW.2022.9250060 · DOI
- Liu, 2021, Blautia—A new functional genus with potential probiotic properties?, Gut Microbes, 13, 1875796, 10.1080/19490976.2021.1875796 · DOI · Paper page
- Hijová, E. (2023). Benefits of Biotics for Cardiovascular Diseases. Int. J. Mol. Sci., 24. · DOI
- Selma, M.V., Beltrán, D., Luna, M.C., Romo-Vaquero, M., García-Villalba, R., Mira, A., Espín, J.C., and Tomás-Barberán, F.A. (2017). Isolation of human intestinal bacteria capable of producing the bioactive metabolite isourolithin a from ellagic acid. Front. Microbiol., 8. · DOI · Paper page
- Zhao, Y., Zhong, X., Yan, J., Sun, C., Zhao, X., and Wang, X. (2022). Potential roles of gut microbes in biotransformation of natural products: An overview. Front. Microbiol., 13. · DOI
- Li, D., Li, Y., Yang, S., Lu, J., Jin, X., and Wu, M. (2022). Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics. Biomed. Pharmacother., 153. · DOI · Paper page
- Breton, J., Galmiche, M., and Déchelotte, P. (2022). Dysbiotic gut bacteria in obesity: An overview of the metabolic mechanisms and therapeutic perspectives of next-generation probiotics. Microorganisms, 10. · DOI · Paper page
- Cheng, 2022, The next generation beneficial actions of novel probiotics as potential therapeutic targets and prediction tool for metabolic diseases, J. Food Drug Anal., 30, 1, 10.38212/2224-6614.3396 · DOI
- Kim, 2013, Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production, Biochem. Biophys. Res. Commun., 431, 258, 10.1016/j.bbrc.2012.12.121 · DOI · Paper page
- Palade, C.-M., Vulpoi, G.-A., Vulpoi, R.-A., Drug, V.L., Barboi, O.-B., and Ciocoiu, M. (2022). The Biotics Family: Current Knowledge and Future Perspectives in Metabolic Diseases. Life, 12. · DOI
- Mao, K., Gao, J., Wang, X., Li, X., Geng, S., Zhang, T., Sadiq, F.A., and Sang, Y. (2022). Bifidobacterium animalis subsp. lactis BB-12 has effect against obesity by regulating gut microbiota in two phases in human microbiota-associated rats. Front. Nutr., 8. · DOI
- Jiang, T., Li, Y., Li, L., Liang, T., Du, M., Yang, L., Yang, J., Yang, R., Zhao, H., and Chen, M. (2022). Bifidobacterium longum 070103 Fermented Milk Improve Glucose and Lipid Metabolism Disorders by Regulating Gut Microbiota in Mice. Nutrients, 14. · DOI
- Kim, G., Yoon, Y., Park, J.H., Park, J.W., Noh, M.-g., Kim, H., Park, C., Kwon, H., Park, J.-h., and Kim, Y. (2022). Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity. Microbiome, 10. · DOI
- Hao, 2022, The antidiabetic effects of Bifidobacterium longum subsp. longum BL21 through regulating gut microbiota structure in type 2 diabetic mice, Food Funct., 13, 9947, 10.1039/D2FO01109C · DOI
- Kim, J.E., Lee, J.Y., and Kang, C.-H. (2022). Limosilactobacillus fermentum MG4295 Improves Hyperglycemia in High-Fat Diet-Induced Mice. Foods, 11. · DOI
- Li, 2022, Effect of Lactobacillus fermentum hfy06 combined with arabinoxylan on reducing lipid accumulation in mice fed with high-fat diet, Oxidative Med. Cell. Longev., 2022, 1068845
- Zhao, 2022, Lactobacillus plantarum S9 alleviates lipid profile, insulin resistance, and inflammation in high-fat diet-induced metabolic syndrome rats, Sci. Rep., 12, 15490, 10.1038/s41598-022-19839-5 · DOI
- Gu, 2022, Lactobacillus paracasei IMC 502 ameliorates type 2 diabetes by mediating gut microbiota–SCFA–hormone/inflammation pathway in mice, J. Sci. Food Agric., 103, 2949, 10.1002/jsfa.12267 · DOI
- Miao, 2022, Lacticaseibacillus paracasei k56 attenuates high-fat diet-induced obesity by modulating the gut microbiota in mice, Probiotics Antimicrob. Proteins, 15, 844, 10.1007/s12602-022-09911-x · DOI
- Chen, 2022, Lactobacillus rhamnosus Strain LRH05 Intervention Ameliorated Body Weight Gain and Adipose Inflammation via Modulating the Gut Microbiota in High-Fat Diet-Induced Obese Mice, Mol. Nutr. Food Res., 66, 2100348, 10.1002/mnfr.202100348 · DOI
- Hosomi, 2022, Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota, Nat. Commun., 13, 4477, 10.1038/s41467-022-32015-7 · DOI · Paper page
- Macarulla, 2023, Relationship between changes in microbiota induced by resveratrol and its anti-diabetic effect on type 2 diabetes, Front. Nutr., 9, 1084702, 10.3389/fnut.2022.1084702 · DOI
- Mazier, W., Le Corf, K., Martinez, C., Tudela, H., Kissi, D., Kropp, C., Coubard, C., Soto, M., Elustondo, F., and Rawadi, G. (2021). A new strain of Christensenella minuta as a potential biotherapy for obesity and associated metabolic diseases. Cells, 10. · DOI
- Pető, Á., Kósa, D., Szilvássy, Z., Fehér, P., Ujhelyi, Z., Kovács, G., Német, I., Pócsi, I., and Bácskay, I. (2023). Scientific and Pharmaceutical Aspects of Christensenella minuta, a Promising Next-Generation Probiotic. Fermentation, 9. · DOI
- Ang, W.-S., Law, J.W.-F., Letchumanan, V., Hong, K.W., Wong, S.H., Ab Mutalib, N.S., Chan, K.-G., Lee, L.-H., and Tan, L.T.-H. (2023). A Keystone Gut Bacterium Christensenella minuta—A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases. Foods, 12. · DOI
- Sun, 2023, Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a, Nat. Commun., 14, 7740, 10.1038/s41467-023-43622-3 · DOI · Paper page
- Cuffaro, B., Boutillier, D., Desramaut, J., Jablaoui, A., Werkmeister, E., Trottein, F., Waligora-Dupriet, A.-J., Rhimi, M., Maguin, E., and Grangette, C. (2023). Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity. Cells, 12. · DOI
- Vallianou, N.G., Kounatidis, D., Tsilingiris, D., Panagopoulos, F., Christodoulatos, G.S., Evangelopoulos, A., Karampela, I., and Dalamaga, M. (2023). The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives. Int. J. Mol. Sci., 24. · DOI
- Wang, 2019, Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids, Cell Rep., 26, 222, 10.1016/j.celrep.2018.12.028 · DOI · Paper page
- Yong, 2020, Antidepressive mechanisms of probiotics and their therapeutic potential, Front. Neurosci., 13, 1361, 10.3389/fnins.2019.01361 · DOI · Paper page
- Sharma, 2021, Psychobiotics: The next-generation probiotics for the brain, Curr. Microbiol., 78, 449, 10.1007/s00284-020-02289-5 · DOI
- Tillmann, S., Awwad, H., Eskelund, A., Treccani, G., Geisel, J., Wegener, G., and Obeid, R. (2017). Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 affect one-carbon metabolism in depressive-like rats. Proc. Neurogastroenterol. Motil., 87.
- Tillmann, 2018, Probiotics Affect One-Carbon Metabolites and Catecholamines in a Genetic Rat Model of Depression, Mol. Nutr. Food Res., 62, 1701070, 10.1002/mnfr.201701070 · DOI
- Philippe, 2020, A probiotic mixture induces anxiolytic-and antidepressive-like effects in Fischer and maternally deprived Long Evans rats, Front. Behav. Neurosci., 14, 214
- Gu, 2020, Lactobacillus casei improves depression-like behavior in chronic unpredictable mild stress-induced rats by the BDNF-TrkB signal pathway and the intestinal microbiota, Food Funct., 11, 6148, 10.1039/D0FO00373E · DOI
- Liu, Y.-W., Liong, M.T., Chung, Y.-C.E., Huang, H.-Y., Peng, W.-S., Cheng, Y.-F., Lin, Y.-S., Wu, Y.-Y., and Tsai, Y.-C. (2019). Effects of Lactobacillus plantarum PS128 on children with autism spectrum disorder in Taiwan: A randomized, double-blind, placebo-controlled trial. Nutrients, 11. · DOI · Paper page
- Kalenik, A., Kardaś, K., Rahnama, A., Sirojć, K., and Wolańczyk, T. (2021). Gut microbiota and probiotic therapy in ADHD: A review of current knowledge. Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 110. · DOI
- Mehrabadi, S., and Sadr, S.S. (2020). Assessment of probiotics mixture on memory function, inflammation markers, and oxidative stress in an Alzheimer’s disease model of rats. Iran. Biomed. J., 24. · DOI
- Den, 2020, Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer’s disease or mild cognitive impairment—A meta-analysis of randomized controlled trials, Aging, 12, 4010, 10.18632/aging.102810 · DOI · Paper page
- Liu, 2022, Lactic acid bacteria feeding reversed the malformed eye structures and ameliorated gut microbiota profiles of Drosophila melanogaster Alzheimer’s disease model, J. Appl. Microbiol., 132, 3155, 10.1111/jam.14773 · DOI
- Cheng, 2022, Lactobacillus paracasei PS23 improves cognitive deficits via modulating the hippocampal gene expression and the gut microbiota in D-galactose-induced aging mice, Food Funct., 13, 5240, 10.1039/D2FO00165A · DOI
- Tarnaud, F., Gaucher, F., Do Carmo, F.L.R., Illikoud, N., Jardin, J., Briard-Bion, V., Guyomarc’h, F., Gagnaire, V., and Jan, G. (2020). Differential Adaptation of Propionibacterium freudenreichii CIRM-BIA129 to Cow’s Milk Versus Soymilk Environments Modulates Its Stress Tolerance and Proteome. Front. Microbiol., 11. · DOI
- Torii, 2011, Effects of oral administration of Lactobacillus acidophilus L-92 on the symptoms and serum markers of atopic dermatitis in children, Int. Arch. Allergy Immunol., 154, 236, 10.1159/000321110 · DOI
- Kim, 2010, Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial, Pediatr. Allergy Immunol., 21, e386, 10.1111/j.1399-3038.2009.00958.x · DOI · Paper page
- Gueniche, 2010, Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro, Eur. J. Dermatol., 20, 731
- Gudadappanavar, 2017, Influence of Lactobacillus acidophilus and Lactobacillus plantarum on wound healing in male Wistar rats-an experimental study, Int. J. Appl. Basic Med. Res., 7, 233, 10.4103/ijabmr.IJABMR_329_16 · DOI
- Gao, T., Wang, X., Li, Y., and Ren, F. (2023). The Role of Probiotics in Skin Health and Related Gut–Skin Axis: A Review. Nutrients, 15. · DOI · Paper page
- Barbosa, J.C., Machado, D., Almeida, D., Andrade, J.C., Brandelli, A., Gomes, A.M., and Freitas, A.C. (2022). Probiotics, Elsevier.
- Dinleyici, 2015, Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting, J. Pediatr., 91, 392, 10.1016/j.jped.2014.10.009 · DOI
- Wang, 2020, Lactobacillus reuteri promotes intestinal development and regulates mucosal immune function in newborn piglets, Front. Vet. Sci., 7, 42, 10.3389/fvets.2020.00042 · DOI
- Nakphaichit, 2019, Protective effect of Lactobacillus reuteri KUB-AC5 against Salmonella enteritidis challenge in chickens, Benef. Microbes, 10, 43, 10.3920/BM2018.0034 · DOI
- Mu, Q., Tavella, V.J., and Luo, X.M. (2018). Role of Lactobacillus reuteri in human health and diseases. Front. Microbiol., 9. · DOI · Paper page
- Petrova, M.I., Imholz, N.C., Verhoeven, T.L., Balzarini, J., Van Damme, E.J., Schols, D., Vanderleyden, J., and Lebeer, S. (2016). Lectin-like molecules of Lactobacillus rhamnosus GG inhibit pathogenic Escherichia coli and Salmonella biofilm formation. PLoS ONE, 11. · DOI
- Burkholder, 2009, Salmonella enterica serovar Typhimurium adhesion and cytotoxicity during epithelial cell stress is reduced by Lactobacillus rhamnosus GG, Gut Pathog., 1, 14, 10.1186/1757-4749-1-14 · DOI
- Guan, C., Su, J., Li, F., Zhang, W., Chen, D., Chen, X., Huang, Y., Zhang, C., and Gu, R. (2023). Isolation and identification of Lacticaseibacillus rhamnosus YT and the antibacterial characteristics of its cell free supernatant and cells. preprint. · DOI
- Gaddawi, 2023, Effect of Lactobacillus acidophilus and Pediococcus pentosaceus on spvR gene expression of Salmonella enterica serovar Enteritidis (S. enteritidis), HIV Nurs., 23, 161
- Omidi, 2022, Effects of Dietary Fermented Red Grape Vinegar and Lactobacillus acidophilus on Growth Performance and Hematobiochemical and Immune Parameters in Juvenile Rainbow Trout, N. Am. J. Aquac., 84, 229, 10.1002/naaq.10232 · DOI
- Hossain, 2022, Inhibition of pathogenic microbes by the lactic acid bacteria Limosilactobacillus fermentum strain LAB-1 and Levilactobacillus brevis strain LAB-5 isolated from the dairy beverage borhani, Curr. Res. Nutr. Food Sci. J., 10, 928, 10.12944/CRNFSJ.10.3.10 · DOI
- Ren, 2022, The Probiotic Lactobacillus paracasei Ameliorates Diarrhea Cause by Escherichia coli O8 via Gut Microbiota Modulation1, Front. Nutr., 9, 878808, 10.3389/fnut.2022.878808 · DOI
- Soltani, N., Abbasi, S., Baghaeifar, S., Taheri, E., Jadid, M.F.S., Emami, P., Abolhasani, K., and Aslanshirzadeh, F. (2022). Antibacterial and antibiofilm activity of Lactobacillus strains secretome and extraction against Escherichia coli isolated from urinary tract infection. Biotechnol. Rep., 36. · DOI
- Hashemi, 2022, Antimicrobial activity of bacterial cell and cell free culture supernatant of Lactobacillus helveticus in-vitro and in a food model, J. Food Sci. Technol., 19, 1
- Fitzpatrick, 2011, Bacillus coagulans GBI-30 (BC30) improves indices of Clostridium difficile-induced colitis in mice, Gut Pathog., 3, 16, 10.1186/1757-4749-3-16 · DOI
- Nyangale, 2014, Effect of prebiotics on the fecal microbiota of elderly volunteers after dietary supplementation of Bacillus coagulans GBI-30, 6086, Anaerobe, 30, 75, 10.1016/j.anaerobe.2014.09.002 · DOI
- Han, F., Wu, G., Zhang, Y., Zheng, H., Han, S., Li, X., Cai, W., Liu, J., Zhang, W., and Zhang, X. (2020). Streptococcus thermophilus attenuates inflammation in septic mice mediated by gut microbiota. Front. Microbiol., 11. · DOI
- Shu, 2001, Probiotic treatment using Bifidobacterium lactis HN019 reduces weanling diarrhea associated with rotavirus and Escherichia coli infection in a piglet model, J. Pediatr. Gastroenterol. Nutr., 33, 171
- Silva, 2004, Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice, J. Appl. Microbiol., 97, 29, 10.1111/j.1365-2672.2004.02265.x · DOI
- Gautier, T., David-Le Gall, S., Sweidan, A., Tamanai-Shacoori, Z., Jolivet-Gougeon, A., Loréal, O., and Bousarghin, L. (2021). Next-generation probiotics and their metabolites in COVID-19. Microorganisms, 9. · DOI
- Jiang, 2021, Pediococcus pentosaceus, a future additive or probiotic candidate, Microb. Cell Factories, 20, 45, 10.1186/s12934-021-01537-y · DOI · Paper page
- Qi, Y., Huang, L., Zeng, Y., Li, W., Zhou, D., Xie, J., Xie, J., Tu, Q., Deng, D., and Yin, J. (2021). Pediococcus pentosaceus: Screening and application as probiotics in food processing. Front. Microbiol., 12. · DOI
- Park, S.-K., Jin, H., Song, N.-E., and Baik, S.-H. (2023). Probiotic Properties of Pediococcus pentosaceus JBCC 106 and Its Lactic Acid Fermentation on Broccoli Juice. Microorganisms, 11. · DOI
- Ma, 2022, Engineered probiotics, Microb. Cell Factories, 21, 72, 10.1186/s12934-022-01799-0 · DOI
- Praveschotinunt, 2019, Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut, Nat. Commun., 10, 5580, 10.1038/s41467-019-13336-6 · DOI · Paper page
- Ji, P., An, B., Jie, Z., Wang, L., Qiu, S., Ge, C., Wu, Q., Shi, J., and Huo, M. (2023). Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy. Mater. Today Bio, 18. · DOI
- Wang, 2023, A bioengineered probiotic for the oral delivery of a peptide Kv1. 3 channel blocker to treat rheumatoid arthritis, Proc. Natl. Acad. Sci. USA, 120, e2211977120, 10.1073/pnas.2211977120 · DOI
- Wu, 2022, Engineered Probiotic Lactococcus lactis for Lycopene Production against ROS Stress in Intestinal Epithelial Cells, ACS Synth. Biol., 11, 1568, 10.1021/acssynbio.1c00639 · DOI
- Saeidi, N., Wong, C.K., Lo, T.M., Nguyen, H.X., Ling, H., Leong, S.S.J., Poh, C.L., and Chang, M.W. (2011). Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol. Syst. Biol., 7. · DOI · Paper page
- Kwon, S.Y., and Min, J.-J. (2014). Gene Therapy of Cancer, Elsevier.
- Liang, 2019, Genetically engineered Salmonella typhimurium: Recent advances in cancer therapy, Cancer Lett., 448, 168, 10.1016/j.canlet.2019.01.037 · DOI
- Nguyen, 2010, Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer, Cancer Res., 70, 18, 10.1158/0008-5472.CAN-09-3453 · DOI · Paper page
- Yoon, 2018, Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment, Ann. Oncol., 29, 2010, 10.1093/annonc/mdy240 · DOI
- Zhang, T., Zhang, J., and Duan, L. (2023). The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review. Nutrients, 15. · DOI
- Chua, 2017, Designer probiotics for the prevention and treatment of human diseases, Curr. Opin. Chem. Biol., 40, 8, 10.1016/j.cbpa.2017.04.011 · DOI
- Ulsemer, 2013, Specific humoral immune response to the Thomsen-Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6, Cancer Immunol. Immunother., 62, 875, 10.1007/s00262-013-1394-x · DOI
- Panteli, 2016, Engineered bacteria detect spatial profiles in glucose concentration within solid tumor cell masses, Biotechnol. Bioeng., 113, 2474, 10.1002/bit.26006 · DOI
- Camacho, 2016, Engineering Salmonella as intracellular factory for effective killing of tumour cells, Sci. Rep., 6, 30591, 10.1038/srep30591 · DOI
- Yoon, 2017, Application of genetically engineered Salmonella typhimurium for interferon-gamma–induced therapy against melanoma, Eur. J. Cancer, 70, 48, 10.1016/j.ejca.2016.10.010 · DOI
- Yanagibashi, 2013, IgA production in the large intestine is modulated by a different mechanism than in the small intestine: Bacteroides acidifaciens promotes IgA production in the large intestine by inducing germinal center formation and increasing the number of IgA+ B cells, Immunobiology, 218, 645, 10.1016/j.imbio.2012.07.033 · DOI · Paper page
- Langella, 2017, Use of traditional and genetically modified probiotics in human health: What does the future hold?, Microbiol. Spectr., 5, 10-1128
- Hinc, 2015, Recombinant Bacillus subtilis spores elicit Th1/Th17-polarized immune response in a murine model of Helicobacter pylori vaccination, Mol. Biotechnol., 57, 685, 10.1007/s12033-015-9859-0 · doi:10.1007/s12033-015-9859-0
- Zhou, 2015, Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores, J. Med. Microbiol., 64, 104, 10.1099/jmm.0.076430-0 · DOI
- Chamcha, 2015, Oral immunization with a recombinant Lactococcus lactis–expressing HIV-1 antigen on group A Streptococcus pilus induces strong mucosal immunity in the gut, J. Immunol., 195, 5025, 10.4049/jimmunol.1501243 · DOI
- Rosique, 2014, Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model, J. Clin. Gastroenterol., 48, S12, 10.1097/MCG.0000000000000235 · DOI
- Steidler, 2000, Treatment of murine colitis by Lactococcus lactis secreting interleukin-10, Science, 289, 1352, 10.1126/science.289.5483.1352 · DOI · Paper page
- Hanson, 2014, Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice, Gastroenterology, 146, 210, 10.1053/j.gastro.2013.09.060 · DOI · Paper page
- Ricci, S., Macchia, G., Ruggiero, P., Maggi, T., Bossù, P., Xu, L., Medaglini, D., Tagliabue, A., Hammarström, L., and Pozzi, G. (2003). In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii. BMC Biotechnol., 3. · DOI
- Caluwaerts, 2010, AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis, Oral Oncol., 46, 564, 10.1016/j.oraloncology.2010.04.008 · DOI
Cited by
Probiotic Development Strategy Centered on Stability and Regulatory Considerations
Kim, H., Haque, M. A., Razzak, M. A., Jang, M. J., Song, S., & Ku, S. (2026) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70320 · Cited by 43
Next‐Generation Probiotics: From Traditional Strains to Personalized Therapeutics
Jadhav, N. K., Magdum, A. B., Shinde, K. V., & Nimbalkar, M. S. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70339 · Cited by 29
Current Concepts in Probiotic Safety and Efficacy
Churin, A. A., Sokolyanskaya, L. O., Lukina, A. P., & Karnachuk, O. V. (2026) · Nutrients · doi:10.3390/nu18040696 · Cited by 31
“NGPs, as well as biotherapeutic drugs (LBP) or medicinal products, must undergo pharmaceutical clinical trials and studies of their pharmacokinetics and pharmacodynamics with the wide use of new technologies such as genetic sequencing and bioinformatics [22].”
Jo, D.-M., Ko, S.-C., Kim, K. W., Yang, D., Kim, J.-Y., Oh, G.-W., Choi, G., Lee, D.-S., Tabassum, N., Kim, Y.-M., et al. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.105309 · Cited by 20
Lu, W., Zha, B., Lyu, J., LingHu, C., Chen, J., Deng, S., Zhang, X., Li, L., & Wang, G. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1500886 · Cited by 4
Metadata
- Authors
- Abouelela, M. E., & Helmy, Y. A.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2024-02-20
- Volume
- 12
- Issue
- 3
- Pages
- 430
- ISSN
- 2076-2607 (ISSN-L)
- OpenAlex
- W4391955640
- Cited by
- 238
- References
- 28
- FWCI
- 46.35
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- U.S. Department of Agriculture (USDA) National Institute for Food and Agriculture (NIFA) (2022-09086, NIH P20 GM130456, KL2TR001996, UL1TR001998)
- Center of Biomedical Research Excellence (COBRE) for Translational Chemical Biology (2022-09086, NIH P20 GM130456, KL2TR001996, UL1TR001998)
- National Center for Advancing Translational Sciences, National Institutes of Health (2022-09086, NIH P20 GM130456, KL2TR001996, UL1TR001998)
- University of Kentucky Igniting Research Collaborations program (2022-09086, NIH P20 GM130456, KL2TR001996, UL1TR001998)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. https://app.cochat.ai/papers/10.3390/microorganisms12030430
- The paper
- Abouelela, M. E., & Helmy, Y. A. (2024). Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. Microorganisms. https://doi.org/10.3390/microorganisms12030430
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.